The Week in Wearables July 10


Consumer Wearables

Some good points here related to focusing on use cases, not proliferation. The end business value lies in very specific use cases, not the all-embracing platforms needed to support them. Here.

Louis Vuitton launched one of the most expensive Android Wear watches to date. The watch stays true to brand, targeting world travelers with flight tracking and city guide features. Here.

On the other end of the spectrum, TicWatch launched one of the least expensive Android Wear watches to date. All the basic, expected smartwatch features appear to be there – how well they work is another question. Here.

What Jawbone’s demise can teach the fitness wearable market – accuracy and user experience matter. It sounds obvious but there’s still much work to be done in wearables on these fronts. Here.

Interesting insights from Fitbit CEO James Park on the company’s next growth areas. Here.

This article on Apple’s testing lab for the Apple Watch provides more detail than I’ve seen publicly on the scale and scope of their efforts. Here.

Good summary of how Firstbeat makes sense of wearable sensor data. Here.

Medical Wearables

Results of a definitive clinical trial show that a new, disposable diagnostic patch effectively detects obstructive sleep apnea across all severity levels. Here.

You may recall Fitbit said recently they’re going after diagnosing and monitoring sleep apnea. Here.

Interesting look at vocal biomarkers in healthcare diagnostics and prevention. Here.

Good summary of uses for VR in therapeutics, including pain management in healthcare facilities. I saw a demo of VR for pain management recently and it has huge potential to make an impact on public health on a broad scale, particularly in light of the opioid crisis. Here.


Rock Health: digital health funding hits $3.5B in first half of 2017. Here.

Leave a Reply

Your email address will not be published. Required fields are marked *